Omar Hamdy

Omar Hamdy is a seasoned professional in the biotech and pharmaceutical sectors with extensive experience in project management, portfolio strategy, and corporate development. Currently serving as Vice President and Head of Portfolio Strategy at Crinetics Pharmaceuticals since May 2023, Omar previously held various leadership roles at Applied Molecular Transport, including Director of Corporate Development and Head of Project Management. Omar's background includes significant positions at AbbVie and its subsidiary Stemcentrx, where responsibilities spanned from project management to analytical chemistry, focusing on antibody drug conjugates (ADCs) and innovative LC-MS technologies. Omar holds an MBA from the University of California, Berkeley, and a Ph.D. in Analytical Chemistry from the University of California, Riverside, supplemented by prior academic accomplishments in Chemistry at William & Mary.